[Progress in locked nucleic acid research]
- PMID: 14992013
[Progress in locked nucleic acid research]
Abstract
Locked nucleic acid (LNA) is a novel oligonucleotide analogue in which 2'-O and 4'-C positions in the b-D-ribofuranosyl ring are joined via an O-methylene, S-methylene or amino-methylene moiety, locked in a C3'-endol3E north (N)-type furanose conformation. LNAs posses many properties, such as extraordinarily high hybridize affinities for complementary DNA/RNA sequences, remarkable antisense activity, nuclease resistance, good aqueous solubility and none detactable toxicity, et al. LNAs is a most promising molecule for development of diagnostics and therapeutics. For example, apply LNAs to single--nucleotide polymorphisms genotyping, telomerase activity have been efficiently suppressed by LNA oligomers, efficient cleavage of highly structured RNA has been achieved using LNA-modified DNAzymes (LNAzymes), and so on.
Similar articles
-
NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid.Bioconjug Chem. 2004 May-Jun;15(3):449-57. doi: 10.1021/bc034145h. Bioconjug Chem. 2004. PMID: 15149171
-
LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.Biochemistry. 2004 Oct 26;43(42):13233-41. doi: 10.1021/bi0485732. Biochemistry. 2004. PMID: 15491130 Review.
-
Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology.Analyst. 2005 Dec;130(12):1634-8. doi: 10.1039/b507728a. Epub 2005 Oct 19. Analyst. 2005. PMID: 16284662
-
Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.BMC Mol Biol. 2006 Jun 5;7:19. doi: 10.1186/1471-2199-7-19. BMC Mol Biol. 2006. PMID: 16753066 Free PMC article.
-
Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.Curr Opin Mol Ther. 2001 Jun;3(3):239-43. Curr Opin Mol Ther. 2001. PMID: 11497347 Review.
Cited by
-
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.Gene Ther. 2011 Apr;18(4):326-33. doi: 10.1038/gt.2010.133. Epub 2010 Dec 23. Gene Ther. 2011. PMID: 21179173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous